Dysfunction of the BBB in AD is manifested by the accumulation of blood-borne fibrinogen in the hippocampus and perivascular areas of the cortex and is accompanied by reductions in TJ, claudin-5, and GLUT1 in BECs (Wang et al., 2022). The gene discussed is SLC2A1; the disease is Alzheimer disease.